ASX Announcement UPCOMING PRESENTATION OF IMVEXXY ® CLINICAL DATA AT 2026 ISPE ANNUAL MEETING AND BIJUVA ® SALES RECOGNITION Key Points • Upcoming poster presentation at the 2026 ISPE Annual Meeting on the risk of endometrial cancer in postmenopausal women...
Upcoming presentation of Imvexxy clinical data
Filed with ASX ·
6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Mayne Pharma launches Investor Hub
- Initial Director's Interest Notice
- Mayne Pharma Bioshares Summit Presentation
- Notification of cessation of securities - MYX
- Notification regarding unquoted securities - MYX
Later from Mayne Pharma
- Notification of date for release of FY26 results
- 2026 Corporate Governance Statement and Appendix 4G
- 2026 Full Year Results Investor Presentation
- 2026 Appendix 4E and Annual Report
- 2026 Full Year Results Media Release
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma